Natural-product-based
pharmacophores possess considerably more
structural diversity, attractive physicochemical features, and relatively
less toxicity than synthesized drug entities. In this context, our
studies on phaeanthine, a bisbenzylisoquinoline alkaloid isolated
from the rhizomes of Cyclea peltata (Lam) Hook.f & Thoms., showed selective cytotoxicity toward
cervical cancer cells (HeLa) with an IC50 of 8.11 ±
0.04 μM. Subsequent investigation with in silico molecular docking
of phaeanthine displayed preferential binding to the antiapoptotic
protein Akt as reflected by a docking score of −5.023. Interestingly,
the follow-up in vitro assessment of the compound correlated with
mitochondria-mediated apoptosis specifically by downregulating the
expression of Akt and p-Akt, including other antiapoptotic proteins
MCl-1, IGF-2, and XIAP. In the complementary in vitro assessment,
mitochondrial membrane polarization and dynamics of intercellular
cytochrome c validated the intrinsic mechanism of
the apoptotic phenomenon. To the best of our knowledge, this is the
first comprehensive anticancer profiling study of phaeanthine against
HeLa cells.